More babies born with EmbryoGlue
EmbryoGlue is exclusively developed to mimic the conditions in the female uterus in order to help embryos implant after transfer.
According to a number needed to treat (NNT) calculation, based on the Cochrane Review, one additional live birth was achieved for every 14 transfers.
For a clinic with 700 cycles annually, this is one additional baby born per week, or a 20% increase in live births.
Please fill out the form to download the white paper on EmbryoGlue. |
| |
|
|